Professional Documents
Culture Documents
a r t i c l e
i n f o
Article history:
Received 1 September 2011
Received in revised form
16 September 2011
Accepted 19 September 2011
Available online 2 October 2011
Keywords:
Low molecular weight chitosan
Nanoparticles
Monodisperse
Ionic cross-linking
Drug carrier
a b s t r a c t
Chitosan nanoparticles have been extensively studied for drug and gene delivery. In this paper, monodisperse, low molecular weight (LMW) chitosan nanoparticles were prepared by a novel method based on
ionic gelation using sodium tripolyphosphate (TPP) as cross-linking agent. The objective of this study was
to solve the problem of preparation of chitosan/TPP nanoparticles with high degree of monodispersity and
stability, and investigate the effect of various parameters on the formation of LMW chitosan/TPP nanoparticles. It was found that the particle size distribution of the nanoparticles could be signicantly narrowed
by a combination of decreasing the concentration of acetic acid and reducing the ambient temperature
during cross-linking process. The optimized nanoparticles exhibited a mean hydrodynamic diameter of
138 nm with a polydispersity index (PDI) of 0.026 and a zeta potential of +35 mV, the nanoparticles had
good storage stability at room temperature up to at least 20 days.
2011 Elsevier B.V. All rights reserved.
1. Introduction
Chitosan is a linear polysaccharide composed of randomly
distributed -(1-4)-linked d-glucosamine and N-acetyl-dglucosamine. Due to the advantageous biological properties
of chitosan, such as relative non-toxicity, biocompatibility,
biodegradability, cationic properties, bioadhesive characteristics
and permeability-enhancing properties, chitosan-based particles
have been extensively studied for delivery of anti-cancer agents,
therapeutic proteins, genes, antigens, and so on [13]. In recent
years, low molecular weight (LMW) chitosan nanoparticles have
shown great potential in the applications of drug delivery and
non-viral vector for gene delivery [46]. This is because, compared
with high molecular weight (HMW) chitosan, LMW chitosan shows
better solubility, biocompatibility, bioactivity, biodegradability
and even less toxicity [79]. Furthermore, many studies have
emphasized the signicance of size and revealed the advantages
of nanoparticles over the microspheres [10].
Among variety of methods developed to prepare chitosan
nanoparticles, ionic gelation technique has attracted considerable
attention due to this process is non-toxic, organic solvent free, convenient and controllable [11]. Ionic gelation technique is based
22
Fig. 1. Effect of the mass ratio of chitosan to TPP on particle size and zeta potential
by adding different volumes of TPP to 10.0 mL of chitosan solution.
23
24
Table 1
The characteristics of chitosan/TPP particles prepared at different ambient temperatures.
Ambient temperature ( C)
1625
1015
04
a
PDI
150160
135150
130140
Bimodal
Broad unimodal
Narrow unimodal
>0.2
0.10.15
<0.05
higher. As the LMW chitosan we used was readily soluble in ultrapure water, in order to investigate the effect of the concentration
of acetic acid on the formation of chitosan/TPP particles, ve acetic
acid concentrations (0 mg/mL, 0.1 mg/mL, 0.2 mg/mL, 0.5 mg/mL
and 0.8 mg/mL) were used to prepare 0.5 mg/mL chitosan solutions,
respectively. The results are shown in Table 2.
Without addition of acetic acid, the chitosan was less protonated and stable nanoparticles suspension could only form at a
high mass ratio of chitosan to TPP (>4.0:1). For example, as the
mass ratio of chitosan to TPP was 5.0:1, the mean particle size, PDI
and peak width of the particles were 315.6 nm, 0.081 and 71.1 nm,
respectively. At an acetic acid concentration of 0.1 mg/mL, the particles exhibited a bimodal particle size distribution, centered around
164 nm and 850 nm, respectively. However, an acetic acid concentration of 0.2 mg/mL would lead to a unimodal and narrow particle
size distribution, indicating that an appropriate increase in the concentration of acetic acid is conducive to enhance the degree of
protonation of chitosan, which increases the potential capacity of
chitosan to form cross-linking with TPP.
When the acetic acid concentration continued to increase to
0.5 mg/mL and 0.8 mg/mL, comparisons of their particle size distributions (by intensity, by number and by volume, respectively)
are shown in Fig. 4. The results indicate that as the acetic acid concentration is increased from 0.2 mg/mL to 0.8 mg/mL, there are not
only more smaller particles formed, but also an increase in the number of larger particles, resulting in a decrease in the monodispersity
of the particles.
As the concentration of acetic acid is increased from 0.2 mg/mL
to 0.8 mg/mL, an increased amount of NaOH should be consumed
to neutralize the excess acid and adjust the chitosan solution to
pH 4.74.8 since this pH is conducive to the formation of chitosan/TPP nanoparticles with a unimodal size distribution, causing
an increase in the ionic strength of the chitosan solution. In dilute
solution, the intermolecular interaction forces are weak because
of the long distance between chitosan molecules, thus the conformation of the molecules is the most important parameter that
determines the physical properties [19]. In low ionic strength solution, the intramolecular electrostatic repulsion effect, also called
the third electroviscous effect dominates, resulting in the chitosan molecules exist in an extended conformation. However, as
the ionic strength increases, the concentration of counter-ions
is raised which screens the protonated amine groups, and thus
Table 2
Effect of the concentration of acetic acid on the characteristics of chitosan/TPP
particles.a
Fig. 3. Cooling curves of chitosan/TPP nanoparticles suspensions reaction at different ambient temperatures: (A) 25 C, (B) 15 C, (C) 4 C and (D) 4 C with a ow of cold
air. (The data were measured by a temperature probe inserted into the suspension,
sampling rate 1 s, resolution 0.06 C.)
Size (nm)
PDI
0
0.1
0.2
0.5
0.8
Precipitation
196.0
138.1
138.4
137.6
Bimodal
25.4
51.3
67.2
0.204
0.026
0.083
0.124
a
The mass ratio of chitosan to TPP was 3.3:1 and the pH of chitosan solution
was adjusted to 4.74.8, except when the acetic acid concentration was 0 mg/mL, of
which pH remained unchanged.
b
The values were obtained from the particle size distribution by intensity and
were given by the HPPS.
25
Fig. 4. Particle size distributions (A) by intensity, (B) by number and (C) by volume
of chitosan/TPP nanoparticles prepared with different acetic acid concentrations.
The typical morphology of the chitosan/TPP nanoparticles prepared at optimal conditions is shown in Fig. 6. The nanoparticles
exhibited a spherical shape and had a narrow particle size distribution with size in the range of 3050 nm. The discrepancy in the
size of chitosan nanoparticles between DLS and TEM can be that
chitosan nanoparticles swell in aqueous media and DLS gives a
hydrodynamic diameter of nanoparticles, while TEM gives an actual
diameter of nanoparticles in dry state. The part of aggregation of
the chitosan/TPP nanoparticles is probably because that the hydrogen bonding interactions between chitosan nanoparticles gradually
become dominant in the drying process.
It also can be noticed that these nanoparticles have a deeper
color in the core and surface, indicating that these regions have
higher electron density distribution. As TPP contains phosphorus
element, which has a higher electron density than those elements
of chitosan, so it can be inferred that chitosan has higher degree of
cross-linking density with TPP in these regions.
3.9. Colloid stability
The colloidal stability of the chitosan/TPP nanoparticles prepared at optimal conditions was evaluated by storage at room
temperature (1020 C) for different periods of time. The results
showed that after stored at room temperature for 20 days, the liquid
Fig. 5. Schematic representation of ionic crosslinking reaction between chitosan and TPP in (A) low ionic strength solution and (B) high ionic strength solution.
26
Acknowledgment
The authors appreciate Jinzhao Wang and Qiwei Yang for their
assistance in this work.
References
was still a clear suspension with light blue opalescence and the
nanoparticles did not show any statistically signicant change in
particle size and its distribution during the investigation (data not
shown). It was suggested that chitosan/TPP nanogels behaved as
a metastable system, since they underwent spontaneous aggregation and disintegration under very mild conditions in a short
period of time [22]. Our results indicate that these monodisperse
chitosan/TPP nanoparticles have excellent storage stability, which
probably due to the low ionic strength environment, appropriate pH conditions (the nal pH of the suspension was around
5.4), together with the high cross-linking density, small size, narrow particle size distribution and high surface potential of the
particles [13,16,23]. Reducing the storage temperature to 4 C or
using freeze-drying with a cryoprotective agent is expected to further improve the long-term storage stability of the chitosan/TPP
nanoparticles [22,24,25].
4. Conclusions
Although the drug delivery system based on chitosan/TPP
nanoparticles has its own advantages, the polydispersity and
poor stability of the colloids seriously limit the efciency of
nanoparticle-mediated drug delivery. In a polydisperse system,
larger nanoparticles usually have higher drug loading capacity,
while smaller nanoparticles are expected to have higher efciency
of delivering drug to tissues or cells [26]. This contradiction means
that even if the drug carrier system has a high encapsulation efciency, the delivery efciency may be poor. Thus, through the novel
method developed by this study, which allows a highly repeatability of producing monodisperse, LMW chitosan/TPP nanoparticles,
it is expected to further improve the efciency of drug utilization, especially for highly size-dependent applications, such as gene
transfer or delivery of drug via mucosal routes [27,28]. In addition,
several attempts have been made to increase the encapsulation and
release period of drug, and the major problem encountered is the
initial burst release of drug [2931]. This is partly associated with
the low mechanical strength of the chitosan/TPP particles, and the
initial burst release can be reduced by enhancing the mechanical
strength of the particles [32]. It has been found in this study that
an increase in the temperature of chitosan solution and a decrease
in the ionic strength of chitosan solution are expected to promote
the formation of a compact and sufcient cross-linking structure
[1] A. Kumari, S.K. Yadav, S.C. Yadav, Biodegradable polymeric nanoparticles based
drug delivery systems, Colloids and Surfaces B: Biointerfaces 72 (2010) 118.
[2] M. Amidi, E. Mastrobattista, W. Jiskoot, W.E. Hennink, Chitosan-based delivery systems for protein therapeutics and antigens, Advanced Drug Delivery
Reviews 62 (2010) 5982.
[3] V.R. Sinha, A.K. Singla, S. Wadhawan, R. Kaushik, R. Kumria, K. Bansal, S. Dhawan,
Chitosan microspheres as a potential carrier for drugs, International Journal of
Pharmaceutics 274 (2004) 133.
[4] A. Vila, A. Snchez, K. Janes, I. Behrens, T. Kissel, J.L.V. Jato, M.J. Alonso, Low
molecular weight chitosan nanoparticles as new carriers for nasal vaccine
delivery in mice, European Journal of Pharmaceutics and Biopharmaceutics 57
(2004) 123131.
[5] M. Lavertu, S. Mthot, N. Tran-Khanh, M.D. Buschmann, High efciency
gene transfer using chitosan/DNA nanoparticles with specic combinations
of molecular weight and degree of deacetylation, Biomaterials 27 (2006)
48154824.
[6] N. Csaba, M. Kping-Hggrd, M.J. Alonso, Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA
delivery, International Journal of Pharmaceutics 382 (2009) 205214.
[7] M. Lee, J.W. Nah, Y. Kwon, J.J. Koh, K.S. Ko, S.W. Kim, Water-soluble and
low molecular weight chitosan-based plasmid DNA delivery, Pharmaceutical
Research 18 (2001) 427431.
[8] S.C.W. Richardson, H.V.J. Kolbe, R. Duncan, Potential of low molecular mass
chitosan as a DNA delivery system: biocompatibility, body distribution and
ability to complex and protect DNA, International Journal of Pharmaceutics
178 (1999) 231243.
[9] S.Y. Chae, M.K. Jang, J.W. Nah, Inuence of molecular weight on oral absorption
of water soluble chitosans, Journal of Controlled Release 102 (2005) 383394.
[10] T. Jung, W. Kamm, A. Breitenbach, E. Kaiserling, J.X. Xiao, T. Kissel, Biodegradable
nanoparticles for oral delivery of peptides: is there a role for polymers to affect
mucosal uptake, European Journal of Pharmaceutics and Biopharmaceutics 50
(2000) 147160.
[11] S.A. Agnihotri, N.N. Mallikarjuna, T.M. Aminabhavi, Recent advances on
chitosan-based micro- and nanoparticles in drug delivery, Journal of Controlled
Release 100 (2004) 528.
[12] X.Z. Shu, K.J. Zhu, The inuence of multivalent phosphate structure on the
properties of ionically cross-linked chitosan lms for controlled drug release,
European Journal of Pharmaceutics and Biopharmaceutics 54 (2002) 235243.
[13] J. Berger, M. Reist, J.M. Mayer, O. Felt, N.A. Peppas, R. Gurny, Structure and
interactions in covalently and ionically crosslinked chitosan hydrogels for
biomedical applications, European Journal of Pharmaceutics and Biopharmaceutics 57 (2004) 1934.
[29]
[30]
[31]
[32]
[33]
[34]
27